Eugenio Morelli

Eugenio Morelli, MD, is a hematologist-oncologist fully committed to basic and translational cancer research. He currently works as Lead Scientist at Dana-Farber Cancer Institute and is a Research Associate at Harvard Medical School (Boston, MA, USA). 

Morelli received his medical degree at Magna Græcia University, Catanzaro, Italy in 2011. He completed his specialty in Medical Oncology at Magna Græcia University, Catanzaro, Italy in 2017. Afterward, he joined Dana-Farber Cancer Institute as a research fellow and then instructor and lead scientist.

His long-term research interest is to decode the key oncogenic features of noncoding RNAs to unlock their therapeutic potential, with a focus on blood cancers, particularly multiple myeloma. As such, he has deeply investigated the roles of noncoding RNAs in promoting multiple myeloma and pioneered innovative strategies for their targeting, with translation to clinical trials.

Morelli is well-published in the field and received national and international grants from different agencies, including the Leukemia & Lymphoma Society, the American Society of Hematology, the International Myeloma Foundation, and the European Hematology Association. In 2019 and 2021, he received the Young Investigator Award from the International Myeloma Society for his contribution to translational research in myeloma.